VNDA (Vanda Pharmaceuticals) חוב לטווח קצר להון

This chart of current Vanda Pharmaceuticals (VNDA) quotes demonstrates the dynamics of a company whose growth potential is based on patent protection and low costs for mass drug production. The indicator is 0.00. The business relies on external contractors for conducting tests and delivering sleep aids. Additionally, the company complies with environmental regulations regarding reagent recycling and office energy efficiency.

The short-term debt-to-equity ratio measures a company's reliance on quick loans, determining liquidity risk and the Weighted Average Cost of Capital (WACC). Minimizing this ratio reduces the probability of default, although it may limit the pace of expansion. The current short-term debt-to-equity ratio allows for an assessment of the financial stability of Vanda Pharmaceuticals (VNDA). This is critical for the biopharmaceutical sector, where standard costs for environmental oversight and reagent disposal require a stable cash flow.